Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Sunday, August 08, 2021 2:00:22 PM
https://www.prnewswire.com/news-releases/biotech-companies-focused-on-cancer-research-are-being-acquired-at-massive-valuations-300961695.html
Yes, that's quite correct, and this will likely happen to RGBP which I recently predicted an 80% probability.
One major example of that is Kite Pharma being acquired by Gilead Sciences in 2017 for $11.9 Billion to control their only Patent based on mRNA Biotechnology for treating various cancers.
Gilead paid a premium on top of Kite Pharma's Share price for many multiples MORE than it was trading for at the time of acquisition, AND their Patent had NOT yet been approved by the FDA for clinical trials.
Just goes to show you where we are today in RGBP that also has mRNA biotechnology and is in the same cancer treatment space as Kite.
Be well and prosper...
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM